Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-24 @ 4:47 PM
Study NCT ID:
NCT06872450
Status:
COMPLETED
Last Update Posted:
2025-08-08
First Post:
2025-02-25
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Informational Tool for Smoking Cessation in COPD Patients
Sponsor:
Hopital Nord Franche-Comte
Organization:
Study Overview
Official Title:
Implementation and Impact Study of an Informational Tool for Smoking Cessation in COPD Patients
Status:
COMPLETED
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IMPACT-BPCO
Brief Summary:
Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.
Detailed Description:
implementing a tool in the form of an informational intervention with a specific motivational intervention
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: